Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
59.32
-1.76 (-2.88%)
Nov 17, 2026, 4:00 PM EST

SHA:688192 Revenue

Dizal (Jiangsu) Pharmaceutical had revenue of 4.25B CNY in the quarter ending September 30, 2026, with 1,736.09% growth. This brings the company's total for the last twelve months to 4.98B, up 720.14% year-over-year. In the year 2025, Dizal (Jiangsu) Pharmaceutical had annual revenue of 801.14M with 122.60% growth. That makes Dizal (Jiangsu) Pharmaceutical the 9,088th largest company in the world by revenue and 1,431st in China.

Revenue (ttm)
4.98B
Revenue Growth
+720.14%
P/S Ratio
5.54
Revenue / Employee
4.94M
Employees
990
Market Cap
27.59B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025801.14M441.23M122.60%
Dec 31, 2024359.90M268.61M294.24%
Dec 31, 202391.29M--
Dec 31, 2022---
Dec 31, 202110.29M-17.48M-62.95%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.